X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ORCHID PHARMA LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ORCHID PHARMA LTD PFIZER/
ORCHID PHARMA LTD
 
P/E (TTM) x 24.2 -0.8 - View Chart
P/BV x 3.9 0.6 692.5% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 PFIZER   ORCHID PHARMA LTD
EQUITY SHARE DATA
    PFIZER
Mar-16
ORCHID PHARMA LTD
Sep-13
PFIZER/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs2,724194 1,404.1%   
Low Rs1,61135 4,602.9%   
Sales per share (Unadj.) Rs440.9276.5 159.5%  
Earnings per share (Unadj.) Rs48.7-79.2 -61.5%  
Cash flow per share (Unadj.) Rs75.8-43.5 -174.4%  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs462.953.9 858.3%  
Shares outstanding (eoy) m45.7570.45 64.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x4.90.4 1,187.1%   
Avg P/E ratio x44.5-1.4 -3,079.3%  
P/CF ratio (eoy) x28.6-2.6 -1,085.6%  
Price / Book Value ratio x4.72.1 220.6%  
Dividend payout %30.80-   
Avg Mkt Cap Rs m99,1638,067 1,229.3%   
No. of employees `0002.92.8 103.2%   
Total wages/salary Rs m2,7582,527 109.1%   
Avg. sales/employee Rs Th6,981.76,956.1 100.4%   
Avg. wages/employee Rs Th954.5902.5 105.8%   
Avg. net profit/employee Rs Th771.1-1,993.0 -38.7%   
INCOME DATA
Net Sales Rs m20,17019,477 103.6%  
Other income Rs m857407 210.6%   
Total revenues Rs m21,02819,884 105.8%   
Gross profit Rs m4,3101,103 390.9%  
Depreciation Rs m1,2392,519 49.2%   
Interest Rs m55,227 0.1%   
Profit before tax Rs m3,923-6,236 -62.9%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m99511 19.3%   
Tax Rs m1,794-125 -1,433.2%   
Profit after tax Rs m2,228-5,580 -39.9%  
Gross profit margin %21.45.7 377.4%  
Effective tax rate %45.72.0 2,278.2%   
Net profit margin %11.0-28.7 -38.6%  
BALANCE SHEET DATA
Current assets Rs m16,29911,014 148.0%   
Current liabilities Rs m7,59432,060 23.7%   
Net working cap to sales %43.2-108.1 -39.9%  
Current ratio x2.10.3 624.8%  
Inventory Days Days6595 68.8%  
Debtors Days Days2634 76.7%  
Net fixed assets Rs m8,62229,440 29.3%   
Share capital Rs m458705 64.9%   
"Free" reserves Rs m20,7222,043 1,014.5%   
Net worth Rs m21,1803,800 557.4%   
Long term debt Rs m259,018 0.3%   
Total assets Rs m29,13746,510 62.6%  
Interest coverage x755.5-0.2 -391,197.4%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x0.70.4 165.3%   
Return on assets %7.7-0.8 -1,008.3%  
Return on equity %10.5-146.9 -7.2%  
Return on capital %19.0-3.7 -508.6%  
Exports to sales %0.137.9 0.2%   
Imports to sales %17.522.6 77.3%   
Exports (fob) Rs m127,378 0.2%   
Imports (cif) Rs m3,5264,406 80.0%   
Fx inflow Rs m527,513 0.7%   
Fx outflow Rs m1405,649 2.5%   
Net fx Rs m-881,865 -4.7%   
CASH FLOW
From Operations Rs m3,4361,682 204.3%  
From Investments Rs m-6,991-9,860 70.9%  
From Financial Activity Rs m-6196,644 -9.3%  
Net Cashflow Rs m-4,174-1,535 271.9%  

Share Holding

Indian Promoters % 0.0 32.3 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 4.6 163.0%  
FIIs % 4.9 3.3 148.5%  
ADR/GDR % 0.0 4.6 -  
Free float % 23.7 55.3 42.9%  
Shareholders   85,207 84,811 100.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  TORRENT PHARMA  PLETHICO PHARMA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Plummets 390 Points; Infosys Continues to Fall(01:30 pm)

After opening the day on a negative note, the share markets in India continued to witness selling pressure as Infosys cracked after Vishal Sikka's resignation as MD & CEO.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 18, 2017 02:24 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS